Ironwood Pharma's total assets for Q3 2025 were $396.06M, an increase of 15.49% from the previous quarter. DE:I76 total liabilities were $452.51M for the fiscal quarter, a -30.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.